Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd. by: Graviti Pharmaceuticals Private Limited, Sangareddy, Telangana, India, Dist. by: Rising Phar, NDC 16571-863-03.
Published October 29, 2025 · Recall initiated: September 15, 2025
Summary
FDA records drug Class II recall D-0037-2026, published October 29, 2025 and initiated September 15, 2025. Recalling firm: Graviti Pharmaceuticals Private Limited; Status: Ongoing; Reported quantity: 46,512/30 count bottles; Lot: Batch # BPB124341A, Exp date: 10/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablet/Capsule Specifications
What to do
Voluntary: Firm initiated · Letter
Get an email if BUPROPION HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- BUPROPION HYDROCHLORIDE
- Manufacturer
- Graviti Pharmaceuticals Private Limited
- Distributor
- Product was distributed to 1 distributor and 16 wholesalers/pharmacy retailers nationwide.
- UPC
- 0316571862030
- Lot
- Batch # BPB124341A, Exp date: 10/2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDAKetorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL Single-Dose Vial, For Intramuscular UseOctober 29, 2025
- FDAZICAM" MEDICATED FRUIT DROPS ELDERBERRY FLAVOR, 25-drops per bottle, Distributed by: Church & Dwight Co., Inc.October 29, 2025
- FDAbuPROPion Hydrochloride Extended-release Tablets USP (XL) Once-Daily, 150 mg, 100 Tablets (10 x 10) perJuly 17, 2024
- FDAbuPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for:January 17, 2024
- FDAbuPROPion Hydrochloride Extended-Release Tablets, USP (SR) 200 mg, 60 Tablets bottle, Distributed by: SunDecember 13, 2023
- FDABupropion Hydrochloride Extended-Release Tablets USP (SR), 150 mg, 60 tablets bottle, Rx Only, Distributed by:October 25, 2023
Questions about this recall
Was Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd. by: Graviti Pharmaceuticals Private Limited, Sangareddy, Telangana, India, Dist. by: Rising Phar, NDC 16571-863-03. recalled?
Yes. FDA published recall D-0037-2026 on October 29, 2025. Reported hazard: Failed Tablet/Capsule Specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: BUPROPION HYDROCHLORIDE. UPC: 0316571862030.